TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's disease.

Jeffrey Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.